Agnese C Pippione

7PUBLICATIONS
39CO-AUTHORS
Molecular targetsBiologically active moleculesMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 14, 2024
AI Based Discovery of a New AKR1C3 Inhibitor for Anticancer Applications.

Agnese C Pippione, Chiara Vigato, Cristina Tucciarello

|Sep 26, 2022
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Aryloxyaryl Moiety.

Stefano Sainas, Marta Giorgis, Paola Circosta

|Apr 12, 2021
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Biphenyl Moiety.

Stefano Sainas, Marta Giorgis, Paola Circosta

|Jan 30, 2019
Correction to Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors.

Stefano Sainas, Agnese C Pippione, Elisa Lupino

|Aug 16, 2018
N-Acetyl-3-aminopyrazoles block the non-canonical NF-kB cascade by selectively inhibiting NIK.

Agnese C Pippione, Stefano Sainas, Antonella Federico

|Aug 16, 2018
4-Hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide: a novel inhibitor of the canonical NF-κB cascade.

Agnese C Pippione, Antonella Federico, Alex Ducime

Pageof 2

Frequent Collaborators

7 joint publications

Marco L Lolli

7 joint publications

Donatella Boschi

6 joint publications

Stefano Sainas

6 joint publications

Salam Al-Karadaghi